Emergent Transfusion and Hemolytic Disease of the Fetus and Newborn Risk Mitigation in Females of Childbearing Potential with Life-Threatening Bleeding: A Clinical Practice Guideline.
Journal of the American College of Surgeons · 2025-12-16 · Guideline / consensus
Abstract
BACKGROUND: Timely resuscitation of patients in hemorrhagic shock is lifesaving. Blood product composition for massive transfusion protocols varies (whole blood vs conventional component therapy). Current whole blood inventory is predominantly RhD-positive, raising questions about the transfusion approach for females of childbearing potential (FCP). STUDY DESIGN: Working groups were assembled that included experts in trauma surgery, transfusion medicine, hematology, maternal and fetal medicine, emergency medicine, anesthesiology, neonatology, and pediatrics. Patient stakeholders and ethics representatives were included in each working group. An evidence review team at Johns Hopkins University performed systematic reviews and provided final reports. The Delphi method was used to refine recommendations and practice points for each key question that reflected consideration of the following factors: balance of benefits and harms, certainty of evidence, values and preferences, resource use and costs, ethics, equity, and feasibility. RESULTS: Key questions addressed were strategies to increase blood donation and availability of RhD-negative blood products; optimal blood product for FCPs in hemorrhagic shock whose RhD type is not known and RhD-negative low-titer group O whole blood is not available; indications for Rh immune globulin for postexposure D-alloimmunization prophylaxis in RhD-negative FCPs who received RhD-positive blood products; and timing and performance of antibody screening after RhD-positive blood transfusion in RhD-negative FCPs. Here, we report the detailed literature review and analysis, including articles screened, retrieved, assessed, and included, as well as the recommendations with their rationale. Consensus was achieved for all recommendations and practice points. CONCLUSIONS: These recommendations provide guidance for the optimal resuscitation and postresuscitation care of FCP with life-threatening bleeding.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Blood products · Fluids & blood
Related articles
- Post-Transfusion Management of RhD-Negative Females of Childbearing Potential Who Receive RhD-Positive Low-Titer Group O Whole Blood and Red Blood Cells During Trauma Resuscitation: A Joint Position Statement and Resource Document of the American College of Surgeons Committee on Trauma (ACS-COT), Prehospital Blood Transfusion Coalition (PBTC), National Association of Emergency Medical Services Physicians (NAEMSP), Trauma Hemostasis and Oxygenation Research (THOR) Network, and Allo Hope Foundation (AHF). (J Am Coll Surg, 2026)
- The THOR network best practices for females of childbearing potential with life-threatening hemorrhage: Guidance for emergency medical services and hospitals. (Transfusion, 2026)
- Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries - a systematic review and clinical practice guideline update. (Eur J Trauma Emerg Surg, 2025)
- Rate of Future Hemolytic Disease of the Fetus and Newborn Following the Prehospital Transfusion of RhD-Positive Blood Products to Females of Childbearing Potential in the United States of America. (Prehosp Emerg Care, 2026)
- RhD-Positive Transfusion in Females of Childbearing Potential in Hemorrhagic Shock: Risk, Reality, and Policy. (Prehosp Emerg Care, 2026)
- A prehospital protocol for transfusion of low-titer O-positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn. (Transfusion, 2025)